The expression of laminin and fibronectin isoforms varies with cellular maturation and differentiation and these differences may well influence cellular processes such as adhesion and motility. The basement membrane (BM) of fetal oral squamous epithelium contains the laminin chains, α2, α3, α5, β1, β2, β3, γ1 and γ2. The BM of adult normal oral squamous epithelium comprises the laminin chains, α3, α5, β1, β3, γ1 and γ2. A re-expression of the laminin α2 and β2 chains could be shown in adult hyperproliferative, dysplastic and carcinomatous lesions.
In oral squamous cell carcinoma (OSCC), the cellular differentiation in the invasion front as well as the mode of invasion are crucial for the tumour behaviour. These parameters belong to the so-called new malignancy grading, which yields a better prognostic value than the conventional Broder's grading system (Bryne et al, 1992) . Therefore, an analysis of the extracellular matrix in the invasion front of OSCC may improve the understanding of tumour cell-matrix interactions during malignant growth.
The epithelium-stroma interface is delineated by a distinct extracellular matrix structure, the basement membrane (BM). Structural irregularities of carcinoma BMs, including the loss of BM material, have been known for some time. In OSCC the extent of BM defects correlates with invasive and metastatic potential (Harada et al, 1994; Kobayashi et al, 1995) . In areas with BM defects the invading carcinoma cells may come into contact with the abundant stromal fibronectin matrix.
Recent results have given rise to a new definition of laminin and fibronectin as molecule families (Mandel et al, 1994; Kosmehl et al, 1996) . Laminin is a heterotrimeric molecule with an α, β and γ chain. Laminin isoforms arise from an exchange of single chains and can be identified in situ by chain-specific antibodies. Laminin isoforms are deposited in a maturation and differentiation-dependent manner. Present knowledge of the laminin chain pattern in normal and diseased oral squamous epithelium is only incomplete.
Whilst laminin is quantitatively the most important non-collageneous matrix protein of the BM, fibronectin is nearly ubiquitously distributed. Fibronectin is a high-molecular-mass glycoprotein with a molecular polymorphism generated by alternative processing of the pre-mRNA (alternative splicing) or by posttranslational modifications of the protein itself (de novo glycosylation). Soluble plasma fibronectin (dimeric, alternatively spliced in the IIICS region) is synthesized by hepatocytes and is found in body fluids. Cellular fibronectin is a larger molecule with an additional domain in the IIICS region and is constituent of the extracellular matrix in dimeric or multimeric cross-linked form. Variants of cellular fibronectin arise from further alternative splicing or de novo O-linked glycosylation in the IIICS domain. In contrast to the ubiquitously distributed common cellular fibronectin, the ED-A and the ED-B fibronectin as well as the de novo glycosylated fibronectin isoforms are limited to areas with structural tissue modulation, embryonic tissues, reparative processes and neoplasias (Loridon-Rosa et al, 1990; Xia and Culp, Distribution of laminin and fibronectin isoforms in oral mucosa and oral squamous cell carcinoma 1995; Kornblihtt et al, 1996; Kosmehl et al, 1996; Burton-Wurster et al, 1997) . The isoforms are identifiable using specific monoclonal antibodies (Borsi et al, 1987; Mandel et al, 1992; Carnemolla et al, 1996) . Extracellular matrix molecules influence differentiation, proliferation, migration, and have stabilizing and separating functions (Kosmehl et al, 1996) . To our knowledge, a comparative study focusing on the modulation of the laminin chain pattern in fetal, normal adult, hyperproliferative, or dysplastic oral epithelium and in OSCC of different malignancy grade has not yet been conducted. Although an immunohistochemical study on the expression of so-called oncofetal fibronectins (ED-B and de novo glycosylated fibronectin) in relation to the formation of an invasive phenotype of neoplastic oral epithelium has already been published (Mandel et al, 1994) , the source of the ED-B fibronectin within the carcinoma remains unclear.
MATERIALS AND METHODS

Tissue material
Twenty-seven surgical specimens of squamous cell carcinoma of the oral cavity (tumour invasion front), five samples of normal adult non-neoplastic, two samples of normal fetal (5th-6th month of gestation), five samples of hyperplastic and three samples of dysplastic oral squamous epithelium were available for histological and immunohistochemical investigations. All samples are derived from the Clinic of Maxillofacial Surgery of the Friedrich Schiller University of Jena. Blocks of fresh tissue measuring 4 × 4 × 4 mm were immediately shock-frozen in isopropanol, cooled by liquid nitrogen and stored at -75°C. The diagnosis was made on conventional haematoxylin and eosin (H&E)-stained serial sections and confirmed in the corresponding paraffinembedded tissue. Histological grading of malignancy was performed using the method reported by Bryne et al (1992) . For correlation analysis the tumours were grouped into well-differentiated G1 carcinomas and into moderate to poorly differentiated G2/3 carcinomas.
Immunohistochemistry
Cryostat sections of the respective frozen tissue samples were fixed in ice-cooled acetone for 15 min and subjected to immunohistochemistry. Primary antibodies used are listed in Table 1 . The immunostaining for collagen type IV was used as reference for the BM. The laminin chain immunostainings were interpreted behind this background.
Immunohistochemical staining was performed using the alkaline phosphatase monoclonal anti-alkaline phosphatase (APAAP) method. The primary antibody was incubated for 30 min at room temperature. After washing with Tris buffer, sections were treated with rabbit anti-mouse immunoglobulin (diluted 1:70, Dako, Denmark), and then with the mouse APAAP complex (Dako, Denmark). Both incubations were carried out for 30 min at room temperature. To increase the staining intensity, the incubation with the rabbit anti-mouse immunoglobulin and with the APAAP complex was repeated twice. Naphthol-AS-biphosphate (Sigma, USA) and new fuchsin (Merck, Germany) were used as substrate and developer respectively. To inhibit endogenous tissue enzyme activity, the developing solution was supplemented with 0.25 mmol l -1 levamisole (Sigma, USA). As negative control, the primary antibody was replaced by non-immune serum.
Quantitative evaluation of the laminin chain and collagen type IV immunostainings and statistical analysis
The BM defects for the laminin chains α3, α5, β1, γ1 and collagen type IV were semiquantitatively evaluated in 30 tumour cell clusters per case at the invasion front according to the criteria introduced by Kobayashi et al (1995) and scored as follows:
• continuous linear staining (no BM defects, score 0) • loss of staining in less than 10% of the tumour-stromal interface per tumour cell nest (minor BM defects, score 1)
• loss of staining in less than 50% of the tumour-stromal interface per tumour cell nest (moderate BM defects, score 2)
• loss of staining in more than 50% of the tumour-stromal interface per tumour cell nest (BM defects to a large extent, score 3).
The number of tumour cell clusters with minor, moderate and major BM defects are presented as mean values ± standard deviation (s.d.).
For statistical evaluation of laminin chain and collagen type IV defects in relation to malignancy grade (G1 and G2/3) the products of the score and number of related tumour cell clusters were added up for each tumour. Statistical analysis was done using the Mann-Whitney U-test (SPSS, Microsoft). P < 0.05 was regarded as statistically significant.
In situ hybridization
The cDNA fragment of the ED-B portion of human fibronectin was inserted as a 272 bp BamHI fragment into BamHI digest pBluescriptIIKS+ vector (Stratagene, La Jolla, CA, USA). Sense or antisense RNA probes were generated by in vitro transcription of the XbaI or EcoRI linearized plasmid using digoxigeninlabelled uridine triphosphate as substrate (DIG RNA Labelling Kit, Boehringer Mannheim, Germany) and T3 or T7 RNA polymerase. Unincorporated nucleotides were removed by ethanol precipitation. The precipitate was dissolved in 100-µl diethylpyrocarbonate treated and RNAase inhibitor containing water. The transcripts were analysed by agarose gel electrophoresis and dot blot assay. In situ hybridization was carried out on 7 to 10-µm-thick sections of immediately snap-frozen tissue. Sections were heated for 2 min at 50°C to fix the RNA in the tissue. The sections were allowed to air dry for 30 min and then fixed in 4% (w/v) paraformaldehyde in phosphate-buffered saline (PBS) for 20 min at 4°C. After washing in PBS (1 × 5 min) and 2 × standard saline citrate (SSC) (2 × 5 min), the prehybridization solution was applied on each slide for 60 min at 37°C. The prehybridization solution contained 4 × SSC, 10% dextran sulphate, 1 × Denhardt's solution, 2 mM EDTA, 50% de-ionized formamide, 100 µg ml -1 herring sperm DNA and 100 µg ml -1 tRNA. After removal of this solution, each section was covered with 100 µl of prehybridization solution containing 200-1000 ng ml -1 of DIG-labelled antisense cRNA probe and incubated at 37°C overnight.
As hybridization controls, the antisense cRNA probe was replaced by ED-B sense cRNA or was completely omitted from the hybridization to evaluate the quality of the colour detection system. After hybridization, unbound probe was washed off from the sections as follows: 1 × 5 min with 2 × SSC at 37°C, 3 × 5 min with 60% formamide in 0.2 × SSC at 37°C, and 2 × 5 min with 2 × SSC at room temperature.
Hybridized DIG-labelled cRNA probes were detected using the components of the DIG Nucleic Acid Detection Kit (Boehringer Mannheim, Germany) following the manufacturer's recommended protocol. Colour reaction was carried out for up to 24 h at room temperature.
The ED-B fibronectin mRNA is situ hybridization and the corresponding immunohistochemistry using the monoclonal antibody BC1 and the recombinant antibody CGS1 was performed on 13 OSCC. Four carcinomas were well-differentiated (G1), and nine carcinomas were moderately to poorly differentiated (six G2 and three G3). The number of in situ hybridization signal bearing cells was counted in 10 HPF (× 40) and was correlated to tumour grade (G1, G2/3). To prove statistical significance, the Kruskal-Wallis and Mann-Whitney U-tests were applied (SPSS, Microsoft).
Double staining procedure for α-smooth muscle actin/Von Willebrand factor and ED-B fibronectin synthesis
A combination of in situ hybridization and PAP technique was used for double staining of cells showing ED-B fibronectin synthesis and positivity for alpha-smooth muscle actin or Von Willebrand factor. First, the mRNA in situ hybridization for ED-B fibronectin was performed as described. Second, after thorough rinsing in Tris buffer the PAP procedure for α-smooth muscle actin or Von Willebrand factor visualization was carried out (Kosmehl et al, 1996) .
RESULTS
Analysis of laminin chain distribution
Normal adult oral squamous epithelium In the squamous cell epithelium-stroma interface, a continuous, narrow and sharply contoured BM was demonstrated by collagen type IV immunohistochemistry. An identical BM staining was achieved using antibodies against the laminin chains, α3 (BM165) ( Figure 1D ), α3 (epiligrin), α5, β1, β3, γ1 and γ2. The α1, α2 and β2 laminin chains were not present in the epithelial BM.
Fetal oral squamous epithelium
In addition to the laminin chains of adult oral squamous epithelium (α3 (BM165), α3 (epiligrin), α5, β1, β3, γ1, and γ2) the α2 and β2 chain are also expressed ( Figure 1A-C) . The immunostaining of the BM was continuous and sharply contoured. The α1 chain could not be demonstrated in the epithelial BM.
Hyperplastic and dysplastic oral squamous epithelium
The laminin chains α3 (BM165), α3 (epiligrin), α5, β1, β3, γ1 and γ2 were detected in the epithelial BM. Compared to normal adult oral squamous epithelium the BM showed irregularities that included thickening and a blurred outline. Additionally, a BM staining for the β2 chain could be demonstrated ( Figure 1E) . A α2 laminin chain staining was seen in the BM of few pseudopapillas. Occasionally, small segments with a focal loss of laminin chain immunostaining could be observed in dysplastic lesions. The α1 chain could not be demonstrated in the epithelial BM.
Oral squamous cell carcinoma
The profile of laminin chain expression was similar to that observed in hyperplastic and dysplastic oral squamous epithelium, namely the expression of the laminin α3 (BM165), α3 (epiligrin), α5, β1, β2 ( Figure 1F ), β3, γ1 and γ2 chains which could be demonstrated around the tumour cell nests. Whereas the α1 chain could not be demonstrated in the BM of the carcinomatous epithelium, an α1 immunostaining was achieved in relation to stromal fibro-/myofibroblasts ( Figure 2C ). An α2 laminin chain staining could be observed only focally. Figure 1 Fetal oral mucosa with immunohistochemical demonstration of the laminin α3 chain (A, BM165), laminin α2 chain (B) and laminin β2 chain (C) in the squamous epithelial BM region (30th week of gestation, ×150, without counterstaining). In normal adult epithelium the BM represents a sharp contoured line (D, laminin α3 chain, BM165, ×150, haematoxylin counterstaining). In hyperplastic epithelium a smooth contoured BM with reexpression of the laminin β2 chain is revealed (E, ×150, without counterstaining). The reexpression of the β2 chain is retained in OSCC BM (F, ×300, haematoxylin counterstaining). Demonstration of numerous BM breaks in a less differentiated OSCC by immunostaining for the laminin α3 chain (G, BM165, ×300, without counterstaining) and the laminin γ2 chain (H, ×300, without counterstaining) Figure 2 Demonstration of laminin-5 (α3β3γ2) in the invasion front of a less differentiated OSCC. In addition to the BM staining a focal deposition of the α3 chain (A, BM165, ×300, without counterstaining) and the γ2 chain (B, ×300, without counterstaining) is shown beneath budding tumour cell complexes. A laminin α1 chain staining of the BM is not achieved (C, OSCC, ×150, haematoxylin counterstaining). Immunostaining of oncofetal ED-B fibronectin in the BM region as well as diffuse in the stromal compartment of fetal oral mucosa (D, 19th week of gestation, clone BC-1, ×300 haematoxylin counterstaining). Strong immunostaining of ED-B fibronectin within the stromal compartment of moderate differentiated OSCC using the recombinant antibody CGS1 (E, ×150, haematoxylin counterstaining). OSCC stromal myofibroblasts synthesize ED-B fibronectin as demonstrated by double labelling (ED-B mRNA in situ hybridization, black and α-smooth muscle actin immunohistochemistry, brown) (F, ×150, without counterstaining). In stromal areas with linear alignment of the fibro-/myofibroblasts (desmoplasia) numerous stromal cells bear the ED-B mRNA in situ hybridization signal (G, ×300, without counterstaining). In addition to stromal cells a subset of endothelial cells synthesize ED-B fibronectin as demonstrated by double labelling (H, OSCC, ED-B mRNA in situ hybridization, black and factor VIII associated antigen immunohistochemistry, brown, ×300, without counterstaining)
Two further observations were remarkable: first, the immunolabelling of all observed laminin chains was discontinuous, indicating a focal loss of laminin chains in the epithelial BM region of the invasion front ( Figure 1G -H, Table 2 ). The semiquantitatively assessed loss of laminin chains and collagen type IV showed significant differences between G1 and G2/3 carcinomas (α3: P = 0.0017, α5: P = 0.0017, β1: P = 0.0032, γ1: P = 0.0264 and collagen type IV: P = 0.0037).
Second, an increased staining was achieved for the α3, β3 and γ2 chains in invasive areas. These chains were seen in the cytoplasm of budding tumour cells and outside the BM region in the stroma of the invasion front (Figure 2A-B) .
Whereas the antibodies directed against the laminin α3 chain (BM165 and P3H4) extensively stained stromal areas in the invasion front, a comparable but quantitatively lesser β3 and γ2 chain staining was visible in the corresponding stroma of the invasion front. The monoclonal antibody P3H4 also labelled basal lamina structures of stromal myofibroblasts.
Analysis of oncofetal fibronectin distribution and synthesis
Oncofetal fibronectin immunohistochemistry
In normal adult and hyperplastic oral mucosa, ED-B fibronectin and de novo glycosylated fibronectin were absent. Embryonal mucosa showed a moderate immunoreactivity for oncofetal fibronectins in the BM region and in the subepithelial stroma ( Figure 2D ).
In the 13 OSCC ED-B fibronectin (BC1, CGS1) and de novo glycosylated fibronectin (5C10, FDC-6) could be demonstrated by immunohistochemistry. The immunostaining for ED-B fibronectin and de novo glycosylated fibronectin were restricted to the tumour stroma. The immunostaining pattern of both antibodies against ED-B fibronectin was identical, but the staining of the recombinant antibody was slightly more intensive ( Figure 2E ). Whilst the well-differentiated carcinomas exhibited focal deposits within the stroma and at the invasion front, the moderately/poorly differentiated carcinomas showed a diffuse staining throughout the tumour stroma compartment and at the invasion front. The ED-B fibronectin deposits at the invasion front in well-differentiated carcinomas correlated to the histological aspect of a clumsy invasive carcinoma growth. In addition to the stroma positivity, ED-B fibronectin could also be found immunohistochemically in tumour vessels and in some blood vessels of the pre-existing tissue adjacent to the invasion front ( Figure 2H ).
ED-B fibronectin RNA/RNA in situ hybridization
In eight out of 13 carcinomas (two G1 and six G2/3 carcinomas) ED-B fibronectin mRNA could be shown by in situ hybridization. A clear labelling was observed in cells of the stromal compartment ( Figure 2F ). In G1 carcinomas numerous positive stromal cells with myofibroblastic appearance were identified within the newly formed stroma of verrucous carcinoma projections, in keeping with the immunohistochemical ED-B fibronectin demonstration.
In contrast to the diffuse ED-B fibronectin immunostaining in the G2/G3 carcinomas, the ED-B fibronectin synthesis was limited only to stromal cell foci. The foci were located in newly induced stroma with parallel alignment of myofibroblastic stroma cells (desmoplasia) ( Figure 2G ). Moreover, a few marked fibroblastic and inflammatory cells could focally be seen at the invasion front. A relation between the number of mRNA containing stromal cells and tumour grade could not be observed. This was also evidenced by statistical analysis. Using double labelling of ED-B fibronectin in situ hybridization and α-smooth muscle actin immunostaining numerous ED-B fibronectin mRNA containing stromal cells were identified as myofibroblasts ( Figure 2F ).
DISCUSSION
Laminin chains in the normal oral squamous epithelium
The laminins represent a continuously growing family of proteins (Kosmehl et al, 1996; Miner et al, 1997) , whose members are endowed with different biological functions (Strassburger et al, 1998) . Because skin and oral squamous epithelia bear structural and functional resemblances, their similar laminin chain composition is not surprising (Rousselle et al, 1991; Sollberg et al, 1992) . According to the visualized chains the following laminin isoforms are possible in the BM of normal oral mucosa: laminin-5, -6 and -10.
Laminin-5 (α3β3γ2) is a typical component of epithelial BMs and is considered the biochemical equivalent of the anchoring filaments fixing basal keratinocytes to the BM. Its significance for the mechanical resistance and protective function of the epithelium has been discussed in the literature (Rousselle et al, 1991 (Rousselle et al, , 1995 .
The reports in the literature concerning the distribution of the α1 chain in human tissues were based mostly on the application of the antibody 4C7. Recently, however, the monoclonal antibody 4C7 was shown to recognize the laminin α5 chain of laminin-10 (α5β1γ1) and laminin-11 (α5β2γ1) (Tiger et al, 1997) . Our data highlight the recently described widespread distribution of laminin-10 in the BMs of various tissue types (Durkin et al, 1997; Miner et al, 1997; Kikkawa et al, 1998) .
In contrast to the adult oral squamous epithelium, embryonal oral squamous epithelium showed the presence of the α2 and β2 chains. The following laminin isoforms may be present in the BM of embryonal mucosa: laminin-2, -4, -5, -6, -7, -10 and -11. The α2 chain is mainly associated with the basal lamina of mesenchymal cells (Leivo et al, 1988) . More recent studies indicate that the adult epidermal BM contains little (Sollberg et al, 1992; Squarzoni et al, 1997) or no (Hori et al, 1994 ) laminin α2 chain. Dystroglycan is an important non-integrin receptor for the laminin α2 chain. It is considered crucial for embryonal BM formation (Williamson et al, 1997) and is present in embryonal oral squamous epithelium (unpublished personal observation). Therefore, the expression of the laminin α2 chain in embryonal oral mucosa may be a prerequisite for normal oral morphogenesis.
The α1 chain together with the β1 and γ1 chains forms the prototypic EHS laminin (laminin-1) and is expressed in different BMs (Ryan et al, 1996) . Nevertheless, we were unable, however, to detect the laminin α1 chain in embryonal, normal adult, hyperand dysplastic or carcinomatous epithelial BM using a polyclonal antibody. The specificity of this antibody was checked using normal adult human kidney, with results matching those of Tiger and co-workers (Tiger et al, 1997) . Our findings confirm the limited distribution of the laminin α1 chain observed in rodent tissues Klein et al, 1990 ).
Re-expression of the α2 and β2 chains in hyperplastic, dysplastic and carcinomatous oral squamous epithelium
Because the presence of laminin α2 and β2 chains is a regular finding in embryonic tissues (Iivanainen et al, 1994) , their re-expression in carcinoma indicates a reappearance of embryonic features in BM composition; the following heterotrimeric laminin molecules are possible: laminin-2, -4, -5, -6, -7, -10 and -11.
A re-expression of the β2 chain occurs in vivo not only in OSCC, but also in basal cell carcinoma of the skin (Sollberg et al, 1992) , in proliferating benign and malignant lesions of the breast (Kosmehl et al, 1996) , and regularly in cultured carcinoma cells (the so-called developmental switch) (Miner et al, 1994; Wewer et al, 1994) .
Structural basement membrane alterations in OSCC demonstrated with antibodies specific for different laminin chains
Basement membrane defects could not be seen at light microscope level in normal or hyperplastic oral squamous epithelium. However, using immunolabelling in hyperplastic lesions a doubling of the width was observed comparable with the findings of Kainulainen et al (1997) in oral lichen planus. In dysplasia and carcinoma BM structural irregularities, including reduplication, splitting, attenuation and breaks (Ueno et al, 1997) have been well documented by electron microscopy. Moreover, immunohistochemical BM defects and a loss of corresponding integrins in head and neck squamous cell carcinomas have been reported (Downer et al, 1993; Harada et al, 1994; Kobayashi et al, 1995; Kosmehl et al, 1995a Kosmehl et al, , 1996 . In this study, multifocal breaks of BM continuity were observed in the invasion zone of all carcinomas, regardless of the laminin chain specificity of the antibodies. The number and extent correlated well with the malignancy grade. These findings are in line with the results of Harada et al (1994) and Kobayashi et al (1995) , who found that an increased loss of BM material (antibodies to EHS-laminin) is associated with a rise in metastatic potential. The semiquantitative evaluation of BM defects reveals differences among the various laminin chains. These differences are not surprising, given that laminin isoform expression is contingent on tissue maturation which varies in the carcinoma invasion front.
The result of laminin α3 chain immunolabelling should be emphasized: first, number and extent of BM defects demonstrated with the α3 chain antibodies (BM165 and P3E4) were fewer and less pronounced than the BM defects demonstrated with antibodies specific to the other laminin chains. Second, in the invasion front there were foci with a strong α3 chain staining outside the original BM region close to budding tumour cells. For the γ2 chain of laminin-5, an invasion-associated increased synthesis was demonstrated in adenocarcinoma of the colon (Pyke et al, 1994; Ueno et al, 1997) . In addition, Kainulainen et al (1997) reported a strong deposition of the γ2 chain outside the BM in invasive areas of OSCC. As determined in serial sections, the immunostaining of the α3 chain is more extensive than that of the γ2 chain. The absence of a clear corresponding β1/2 or γ1 chain staining, as well as the demonstrated cytoplasmic accumulation of laminin chains in budding OSCC cells, hint to a disturbed molecule assembly. Comparable results were recently described by Sordat (1998) for colorectal neoplasia.
The focal loss of structural BM organization, and the presence of the γ2 chain and particularly the α3 laminin chain on tumour cell surface and in the stroma adjacent to invasive carcinoma cell clusters, may support the tumour cell invasion (Kosmehl et al, 1996) . Invasion mediated via newly deposited laminin-5 containing BM has previously been suggested in pancreatic adenocarcinoma (Tani et al, 1997) . In case of OSCC cells the invasion related laminin-5 immunostaining is not associated with an organized BM as shown in vitro (Berndt et al, 1997) . Whilst the role of laminin-5 as a strong adhesive for keratinocytes in vivo and in vitro is generally accepted (Rousselle et al, 1991) , the ability to promote keratinocyte migration is still controversial (O'Toole et al, 1997) . Nevertheless, the majority of experiments suggest that it can promote cell motility (Zhang et al, 1996; Tani et al, 1997) .
ED-B fibronectin synthesis indicates tumour stroma recruitment
Our results show that, except for some highly differentiated carcinomas, oncofetal fibronectins (ED-B fibronectin, de novo glycosylated fibronectin) permeate the whole stromal compartment of OSCC (cp. Mandel et al, 1994) . In contrast to OSCC, breast and colon carcinomas display only focal oncofetal fibronectin deposits if at all Pujuguet et al, 1996) . As previously described, newly formed vessels within tumour stroma contain ED-B fibronectin . We have found that some, possibly growth factor-stimulated, blood vessels neighbouring the invasion front are also ED-B fibronectin-positive. The new phage antibody CGS1 (Carnemolla et al, 1996) generates comparable staining patterns to the mouse monoclonal antibody BC1, proving to be a valuable and easy to handle immunohistochemical tool. The in situ hybridization signal for ED-B fibronectin was confined to focal accumulations of spindle-shaped stromal cells with abundant cytoplasm. Based on their immunocytochemical findings in stroma cell cultures of breast carcinomas, Brouty-Boyé and Magnien (1994) suggested that the stromal myofibroblasts were the source of ED-B fibronectin in malignant tumours. Indeed, the ED-B fibronectin in situ hybridization labelled stromal cells show myofibroblastic features by light microscopy. As previously demonstrated also in palmar fibromatosis (Dupuytren's disease), myofibroblasts abundantly synthesize ED-B fibronectin (Kosmehl et al, 1995b) .
A correlation of the number of ED-B fibronectin-positive stromal cells to malignancy grade could not be detected. The focal accumulations of ED-B fibronectin synthesizing cells were found in the stromal compartment of papillary projections of highly differentiated carcinomas (area of stroma formation), or in stromal areas with a parallel alignment of fibro-/myofibroblasts (desmoplasia). Therefore, ED-B fibronectin synthesis may indicate stroma recruitment inclusive of active desmoplastic stroma reaction. The high ED-B fibronectin synthesis during the formation of an aligned fibrocollagenous stroma concurs with the observation of Nickeleit et al (1995) , who found the strongest ED-B fibronectin in situ hybridization signal during the sclerosis stage of experimental autoimmune glomerulonephritis in rats. Moreover, single spindle-shaped cells and groups of inflammatory cells positive for ED-B fibronectin synthesis occur regularly at the invasion front. An expression of ED-B fibronectin in macrophages has already been described in experimental glomerulonephritis and granulation tissue (Barnes et al, 1995) . Because ED-B fibronectin enhances adhesion and spreading of several cell types in vitro (Chen and Culp, 1996; Hashimoto-Uoshima et al, 1997) , the ED-B fibronectin synthesis at the invasion front of OSCC should be discussed in relation to an altered cellular adhesion, an advancement of cellular migration and formation of an invasive phenotype (Kosmehl et al, 1996) .
Embryonic extracellular matrix features in OSCC
The re-expression of a fetal differentiation pattern in malignant tumours (so called retrodifferentiation) has been known for nearly 2 decades (Uriel et al, 1979) . The embryonic phenotype in malignant tumours entails not only the tumour cells themselves, but also the extracellular matrix pattern: re-expression of ED-B fibronectin, de novo glycosylated fibronectin and the laminins-2,-4, -7 and 11. Whereas laminin synthesis is attributed to the epithelial (i.e. carcinoma) cells (Pyke et al, 1994; Ueno et al, 1997) , the oncofetal ED-B fibronectin matrix is generated by recruited stromal cells (myofibroblasts), as evinced in this study. The alternative splicing of fibronectin and the expression of laminin-5 chains by keratinocytes are regulated by the growth factor TGFβ (Borsi et al, 1990; Berndt et al, 1995; Korang et al, 1995) . As a consequence, a co-ordinated extracellular matrix remodelling in the carcinoma invasion front may be suggested.
